Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

NCT00405405 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Parotid Gland Cancer
Thyroid Gland Cancer
Melanoma
Stage IV Head and Neck Cancer

Interventions

DRUG: Cisplatin
DRUG: Docetaxel
DRUG: Bevacizumab
DRUG: Erlotinib
RADIATION: Radiotherapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]